- 01Biome to launch Probiotic 60s for adults and kids
- 02Two-month supply; fivefold more live bacteria to gut
- 03Onshore production via Specialty Probiotics Australia
Biome Australia Group (ASX: BIO) has announced the imminent launch of Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60 to treat gastrointestinal symptoms and the side effects of antibiotics, as well as provide winter immune support.
The Australian-made lines each represent a larger two-month supply of the company’s highest-volume products, microencapsulated so five times more live bacteria reach the gut.
Biome Daily 30 is the current number one probiotic product in Australian pharmacies by unit and value, while Biome Daily Kids 30 is the number one immune health and kids probiotic, based on industry research.
The new products will be supplied through Biome’s existing pharmacy wholesalers and practitioner channel from the first half of 2027, spreading demand across more stock keeping units and derisking supply of its largest lines.
They represent the first items produced under an onshore manufacturing agreement with Specialty Probiotics Australia.
Clinically Supported Products
Biome Daily Probiotic is a six strain, 9 billion live bacteria capsule for adults, formulated for digestive and immune health.
The Lactiplantibacillus plantarum (or HEAL9) and Lacticaseibacillus paracasei (8700:2) strain combination has been studied in randomised, double-blind, placebo-controlled trials on more than 1,400 adults and shown to reduce the incidence, duration, and severity of common colds.
Biome Daily Kids Probiotic is a five strain, 10 billion live bacteria vanilla-flavoured sachet formulated to support immune function, reduce the occurrence and duration of common colds, and maintain healthy gut bacteria during antibiotic use.
Both products use Activated Probiotics microencapsulation (coated) technology, which protects the bacteria through the stomach so that five times more reaches the gut alive than uncoated probiotics.
Adherence and Retention
Probiotics work through consistent daily use, and a two-month supply supports adherence and retention, gives pharmacists and practitioners a simpler recommendation for regular users, and lifts transaction value for pharmacy partners.
Biome’s pricing has been set to retain existing customers as they move to the larger format.
The demand that currently sits on a single SKU for each product will now be spread across two, reducing the impact of any out of stock at wholesaler or retailer level.
With one carton, one label, and one freight movement covering two months of supply, the format is also structurally more efficient for Biome, supporting its objective of lifting gross margin under the Specialty Probiotics Australia agreement.
Encouraging Continued Use
Biome Australia founder and managing director Blair Vega Norfolk said the two-month format would encourage continued use.
“Our probiotics are backed by clinical trials but a trial result only becomes a health outcome if people take the product every day for long enough to get the benefit and the most common reason they stop is running out [of product],” he said.
“A two-month pack helps patients stay on the product and gives the pharmacists and practitioners who support them a simpler recommendation.”
“Fourteen of the top 20 products in the [Australian probiotics] category are larger formats—until now, we have left that part to everyone else.
“That is why this may be the most exciting launch we have done: patients stay on the product longer, practitioners get an easier recommendation, and the category has already told us it wants the format.”
Get the wire before the market opens.
The ASX small-cap stories that matter, filed before 9am AEST. Curated by the Small Caps desk.